GlassScriptPhysician profile
Leon S Perel
NPI 1871754572
$2,876.44
in general payments reported to CMS, 2019-2025
6 companies · $929 in 2025
The $929 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,255 · 2020: $284 · 2021: $57.75 · 2022: $211 · 2023: $52.76 · 2024: $86.78 · 2025: $929.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $650 · Food and Beverage: $418.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $650.00 |
| Food and Beverage | $418.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,716.54 | 2019-2025 | Proclaim, Eterna, Octrode |
| Vertiflex, INC. | $854.99 | 2019 | |
| Boston Scientific Corporation | $130.38 | 2019-2023 | Wavewriter Alpha Prime 16 |
| Curonix LLC | $75.45 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Orexo US, INC. | $72.07 | 2022 | |
| Biodelivery Sciences International, INC. | $27.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leon Perel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.